| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.995 | 0.001 | 0.995 | Opioid mu receptor antagonist | 0.975 0.001 DBMET00760 | ||
| 0.993 | 0.001 | 0.993 | Opioid antagonist | 0.974 0.001 DBMET00760 | ||
| 0.991 | 0.003 | 0.991 | Analgesic | 0.988 0.003 DBMET00760 | ||
| 0.988 | 0.001 | 0.988 | Analgesic, opioid | 0.974 0.001 DBMET00760 | ||
| 0.986 | 0.001 | 0.986 | Opioid delta receptor antagonist | 0.935 0.001 DBMET00760 | ||
| 0.98 | 0.001 | 0.98 | Opioid kappa receptor antagonist | 0.94 0.001 DBMET00760 | ||
| 0.962 | 0.001 | 0.962 | Opioid agonist | 0.945 0.001 DBMET00760 | ||
| 0.938 | 0.001 | 0.938 | Opioid mu receptor agonist | 0.917 0.001 DBMET00760 | ||
| 0.932 | 0.001 | 0.932 | Opioid delta receptor agonist | 0.846 0.001 DBMET00760 | ||
| 0.919 | 0.002 | 0.926 | Antipruritic | 0.926 0.002 DBMET00760 | DBMET00760 | |
| 0.871 | 0.003 | 0.871 | Sigma receptor antagonist | 0.822 0.003 DBMET00760 | ||
| 0.857 | 0.001 | 0.857 | Opioid kappa receptor agonist | 0.814 0.001 DBMET00760 | ||
| 0.767 | 0.002 | 0.767 | Toll-Like receptor antagonist | 0.547 0.003 DBMET00760 | ||
| 0.672 | 0.001 | 0.672 | Toll-Like receptor 4 antagonist | 0.527 0.001 DBMET00760 | ||
| 0.591 | 0.002 | 0.591 | Cyclooxygenase 3 inhibitor | 0.537 0.003 DBMET00760 | ||
| 0.591 | 0.003 | 0.591 | Acetylcholine M1 receptor antagonist | 0.588 0.003 DBMET00760 | ||
| 0.516 | 0.007 | 0.545 | Anesthetic general | 0.545 0.005 DBMET00760 | DBMET00760 | |
| 0.514 | 0.042 | 0.514 | Transcription factor NF kappa B inhibitor | 0.452 0.053 DBMET00760 | ||
| 0.473 | 0.013 | 0.473 | Psychostimulant | 0.349 0.032 DBMET00760 | ||
| 0.433 | 0.034 | 0.709 | Spasmolytic | 0.709 0.005 DBMET00760 | DBMET00760 | |
| 0.366 | 0.003 | 0.369 | Nociceptin (N/OFQ) receptor antagonist | 0.369 0.003 DBMET00760 | DBMET00760 | |
| 0.398 | 0.064 | 0.479 | Immunosuppressant | 0.479 0.039 DBMET00760 | DBMET00760 | |
| 0.332 | 0.009 | 0.332 | Toll-Like receptor 9 antagonist | 0.149 0.064 DBMET00760 | ||
| 0.317 | 0.008 | 0.328 | Acetylcholine muscarinic antagonist | 0.328 0.007 DBMET00760 | DBMET00760 | |
| 0.298 | 0.007 | 0.298 | Breast cancer-resistant protein inhibitor | 0.258 0.009 DBMET00760 | ||
| 0.294 | 0.015 | 0.307 | Cholinergic antagonist | 0.307 0.014 DBMET00760 | DBMET00760 | |
| 0.287 | 0.015 | 0.298 | Acetylcholine antagonist | 0.298 0.014 DBMET00760 | DBMET00760 | |
| 0.299 | 0.041 | 0.313 | Nitric oxide antagonist | 0.313 0.038 DBMET00760 | DBMET00760 | |
| 0.274 | 0.034 | 0.274 | P-glycoprotein inhibitor | 0.234 0.047 DBMET00760 | ||
| 0.257 | 0.025 | 0.275 | Protein kinase stimulant | 0.275 0.021 DBMET00760 | DBMET00760 | |
| 0.254 | 0.028 | 0.254 | Cholinergic | 0.206 0.044 DBMET00760 | ||
| 0.231 | 0.025 | 0.231 | Acetylcholinesterase inhibitor | 0.17 0.044 DBMET00760 | ||
| 0.246 | 0.049 | 0.319 | Sigma receptor agonist | 0.319 0.035 DBMET00760 | DBMET00760 | |
| 0.183 | 0.003 | 0.183 | CC chemokine 5 receptor agonist | 0.177 0.003 DBMET00760 | ||
| 0.209 | 0.059 | 0.296 | Hepatoprotectant | 0.296 0.031 DBMET00760 | DBMET00760 | |
| 0.171 | 0.022 | 0.177 | Antineoplastic alkaloid | 0.177 0.02 DBMET00760 | DBMET00760 | |
| 0.133 | 0.003 | 0.134 | Nociceptin (N/OFQ) receptor agonist | 0.134 0.003 DBMET00760 | DBMET00760 | |
| 0.214 | 0.105 | 0.36 | Antioxidant | 0.36 0.044 DBMET00760 | DBMET00760 | |
| 0.136 | 0.029 | 0.152 | Prolactin inhibitor | 0.152 0.021 DBMET00760 | DBMET00760 | |
| 0.17 | 0.08 | 0.17 | Lipocortins synthesis antagonist | 0.15 0.105 DBMET00760 | ||
| 0.201 | 0.12 | 0.234 | 5 Hydroxytryptamine release stimulant | 0.234 0.097 DBMET00760 | DBMET00760 | |
| 0.114 | 0.04 | 0.114 | Estrogen receptor beta antagonist | 0.105 0.056 DBMET00760 | ||
| 0.122 | 0.052 | 0.122 | Estrogen antagonist | 0.116 0.063 DBMET00760 | ||
| 0.078 | 0.012 | 0.08 | Prolactin release inhibitor | 0.08 0.011 DBMET00760 | DBMET00760 | |
| 0.141 | 0.095 | 0.141 | Melanin inhibitor | 0.141 0.095 DBMET00760 | ||
| 0.204 | 0.159 | 0.229 | Immunomodulator | 0.229 0.133 DBMET00760 | DBMET00760 | |
| 0.078 | 0.038 | 0.088 | Orexin receptor 1 antagonist | 0.088 0.024 DBMET00760 | DBMET00760 | |
| 0.203 | 0.173 | 0.233 | Vasodilator, peripheral | 0.233 0.142 DBMET00760 | DBMET00760 | |
| 0.046 | 0.02 | 0.046 | Estrogen receptor beta agonist | 0.031 0.023 DBMET00760 | ||
| 0.191 | 0.171 | 0.191 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.07 | 0.054 | 0.07 | Dopamine antagonist | |||
| 0.05 | 0.036 | 0.05 | CC chemokine 5 receptor antagonist | 0.05 0.036 DBMET00760 | ||
| 0.071 | 0.059 | 0.083 | Na+ K+ transporting ATPase inhibitor | 0.083 0.047 DBMET00760 | DBMET00760 | |
| 0.029 | 0.017 | 0.031 | Sigma 1 receptor antagonist | 0.031 0.016 DBMET00760 | DBMET00760 | |
| 0.047 | 0.037 | 0.047 | Estrogen agonist | 0.047 0.037 DBMET00760 | ||
| 0.199 | 0.189 | 0.252 | Sodium/bile acid cotransporter inhibitor | 0.252 0.126 DBMET00760 | DBMET00760 | |
| 0.078 | 0.069 | 0.153 | Alpha 2 adrenoreceptor antagonist | 0.153 0.026 DBMET00760 | DBMET00760 | |
| 0.131 | 0.123 | 0.157 | Interleukin 6 antagonist | 0.157 0.079 DBMET00760 | DBMET00760 | |
| 0.017 | 0.009 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.016 0.009 DBMET00760 | ||
| 0.123 | 0.116 | 0.163 | Growth hormone agonist | 0.163 0.077 DBMET00760 | DBMET00760 | |
| 0.19 | 0.185 | 0.219 | Caspase 3 stimulant | 0.219 0.144 DBMET00760 | DBMET00760 | |
| 0.029 | 0.038 | 0.033 | Tubulin agonist | 0.033 0.027 DBMET00760 | DBMET00760 | |
| 0.055 | 0.077 | 0.087 | Antineoplastic antibiotic | 0.087 0.052 DBMET00760 | DBMET00760 | |
| 0.061 | 0.085 | 0.093 | Acetylcholine M3 receptor agonist | 0.093 0.049 DBMET00760 | DBMET00760 | |
| 0.059 | 0.085 | 0.103 | Glycine receptor agonist | 0.103 0.019 DBMET00760 | DBMET00760 | |
| 0.055 | 0.086 | 0.09 | Alpha 2a adrenoreceptor antagonist | 0.09 0.042 DBMET00760 | DBMET00760 | |
| 0.135 | 0.167 | 0.252 | Free radical scavenger | 0.252 0.068 DBMET00760 | DBMET00760 | |
| 0.051 | 0.087 | 0.061 | Orexin receptor antagonist | 0.061 0.056 DBMET00760 | DBMET00760 | |
| 0.069 | 0.117 | 0.127 | Expectorant | 0.127 0.046 DBMET00760 | DBMET00760 | |
| 0.03 | 0.078 | 0.041 | Microtubule stabilization | 0.041 0.04 DBMET00760 | DBMET00760 | |
| 0.076 | 0.127 | 0.095 | Cholesterol synthesis inhibitor | 0.095 0.094 DBMET00760 | DBMET00760 | |
| 0.055 | 0.115 | 0.086 | Glycine receptor antagonist | 0.086 0.048 DBMET00760 | DBMET00760 | |
| 0.214 | 0.312 | 0.319 | Antiinflammatory | 0.319 0.197 DBMET00760 | DBMET00760 | |
| 0.152 | 0.269 | 0.251 | Apoptosis antagonist | 0.251 0.127 DBMET00760 | DBMET00760 | |
| 0.062 | 0.194 | 0.109 | Lipid peroxidase inhibitor | 0.109 0.106 DBMET00760 | DBMET00760 | |
| 0.115 | 0.247 | 0.205 | Hypoglycemic | 0.205 0.107 DBMET00760 | DBMET00760 | |
| 0.044 | 0.256 | 0.117 | DNA polymerase I inhibitor | 0.117 0.07 DBMET00760 | DBMET00760 | |
| 0.073 | 0.319 | 0.155 | Vasodilator | 0.155 0.15 DBMET00760 | DBMET00760 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |